Del. Justices Reverse Express Scripts' $82M Trial Loss

The Delaware Supreme Court on Tuesday threw out a biopharmaceutical company's $82 million jury trial win in a suit alleging Express Scripts Inc. fraudulently skewed its revenues to close a multimillion-dollar...

Already a subscriber? Click here to view full article